RTOG-1216
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer. Click here to learn more.
- Clinical Trials
- Colorectal Cancer
- Paroxysmal Nocturnal Hemoglobulinuria
- Clinical Trials at UCBC
- Bladder Cancer
- Breast Cancer
- Esophageal Cancer
- Gastric Tumors
- Head & Neck Cancer
- Kidney Cancer
- Lung Cancer
- Lymphoma
- Melanoma
- Neuroendocrine Tumors
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Sarcoma Tumors
- Brain & Spinal Cord Tumors
